Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine

Cutis

Volumn 66, Issue 1, 2000, Pages 45-46

  Sevigny, Gina M ^a   Ramos Caro, Francisco A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Div Dermatol and Cutaneous Surg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ARTICLE; BIOPSY; CASE REPORT; CHROMOMYCOSIS; DOSE RESPONSE; DRUG ADMINISTRATION; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; SKIN;

ANTIFUNGAL AGENTS; BIOPSY; CHROMOBLASTOMYCOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; SKIN;

EID: 0034230940     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Restrepo A: Treatment of tropical mycoses. J Am Acad Dermatol 31: S91-S102, 1994.
2. Kullavanijaya P, Rojanavanich V: Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol 34: 804-807, 1995.
3. Esterre P, Inzan CK, Ramarcel ER, et al: Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 134 (Suppl 46): 33-36, 1996.
4. Queiroz-Telles F, Purim KS, Fillus JN, et al: Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 31: 805-812, 1992.
5. Lever WF, Schaumburg-Lever G: Histopathology of the Skin. 7th ed, chap, 19, pp 376-378. Philadelphia, JB Lippincott, 1990.
6. Elewski BE: Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol 28: S28-S34, 1993.
7. Gupta AK, Soori GS, Del Rosso JQ, et al: Severe neutropenia associated with oral terbinafine therapy. J Am Acad Dermatol 38: 765-767, 1998.
8. Hall M, Monka C, Krupp P, et al: Safety of oral terbinafine. Arch Dermatol 133: 1213-1219, 1997.